Anavex Life Sciences Corp (AVXL)

[Rubyred77]

Seems like mission accomplished for BIIB. Their goal was:
Take interest away from AVXL and stay on BIIB. Why else would they want to change presentations to AFTER Anavex.

Make bio markers a side topic and keep amyloid on the front burner. Even though the following shows that even analysts are doubting the Amyloid theory

https://www.statnews.com/2018/07/26/biogen-lost-7-billion-overnight-despite-positive-alzheimers-data/

Even if it costs them many Billions in valuation, that’s more shares needing to be sold by Anavex to raise money when it comes time. They have the money and influence to outlast Anavex financially. Curve ball being while we wait for approval for trial start in the U.S. we will start them in the EU and Australia in the mean time.

Cant wait for both trials to start and watch the haves be separated from the have not.

Then there’s A-371 batting cleanup!!!!